UBS Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-367,480
| Closed | -$42K | – | 7393 |
|
|
2018
Q4 | $42K | Buy |
367,480
+259,871
| +241% | +$29.7K | ﹤0.01% | 5359 |
|
|
2018
Q3 | $183K | Buy |
107,609
+80,869
| +302% | +$138K | ﹤0.01% | 4302 |
|
|
2018
Q2 | $47K | Sell |
26,740
-1,129,333
| -98% | -$1.98M | ﹤0.01% | 5128 |
|
|
2018
Q1 | $2.12M | Sell |
1,156,073
-1,470,904
| -56% | -$2.69M | ﹤0.01% | 2510 |
|
|
2017
Q4 | $5.86M | Sell |
2,626,977
-192,800
| -7% | -$430K | ﹤0.01% | 1717 |
|
|
2017
Q3 | $8.18M | Buy |
2,819,777
+1,674,159
| +146% | +$4.86M | ﹤0.01% | 1393 |
|
|
2017
Q2 | $5.1M | Buy |
1,145,618
+1,082,918
| +1,727% | +$4.82M | ﹤0.01% | 1682 |
|
|
2017
Q1 | $292K | Sell |
62,700
-132,593
| -68% | -$617K | ﹤0.01% | 3617 |
|
|
2016
Q4 | $1.19M | Buy |
195,293
+85,936
| +79% | +$523K | ﹤0.01% | 2693 |
|
|
2016
Q3 | $603K | Sell |
109,357
-68,004
| -38% | -$375K | ﹤0.01% | 3041 |
|
|
2016
Q2 | $674K | Buy |
177,361
+60,994
| +52% | +$232K | ﹤0.01% | 2961 |
|
|
2016
Q1 | $321K | Sell |
116,367
-195,631
| -63% | -$540K | ﹤0.01% | 3447 |
|
|
2015
Q4 | $1.77M | Buy |
311,998
+207,398
| +198% | +$1.18M | ﹤0.01% | 2271 |
|
|
2015
Q3 | $555K | Sell |
104,600
-184,281
| -64% | -$978K | ﹤0.01% | 3037 |
|
|
2015
Q2 | $2.4M | Buy |
288,881
+216,281
| +298% | +$1.8M | ﹤0.01% | 2169 |
|
|
2015
Q1 | $335K | Sell |
72,600
-17,980
| -20% | -$83K | ﹤0.01% | 3465 |
|
|
2014
Q4 | $276K | Buy |
+90,580
| New | +$276K | ﹤0.01% | 3554 |
|